KSQ Therapeutics
Latest round
- Series C
Last raised
- Sep 2018
Total raised
- $156M
Investors
- 8
About KSQ Therapeutics
KSQ Therapeutics, Inc.Founded in 2015 and headquartered in Cambridge, US, KSQ Therapeutics focuses on innovative cancer therapies.KSQ Therapeutics focuses on developing innovative therapies targeting human diseases, particularly through their proprietary CRISPRomics® platform. This platform is designed to identify and manipulate the genome's therapeutic targets with potential curative effects. The company’s key offerings include CRISPR/Cas9-engineered Tumor Infiltrating Lymphocytes (eTIL®), which represent a promising approach in cancer treatment by harnessing the body's immune system to attack tumors. These products aim to address complex medical challenges, primarily in the oncology sector, and are intended for use by healthcare providers and clinical research institutions.KSQ Therapeutics generates revenue primarily through partnerships and collaborations with other biotechnology firms and healthcare organizations. The company engages in transactions involving research agreements and development collaborations, providing access to its CRISPRomics® platform and eTIL® programs for cancer treatment. These agreements often include milestone payments tied to the progress of the therapeutic candidates, as well as potential royalties on future sales of successful products. The business structure emphasizes B2B relationships, targeting pharmaceutical companies eager to leverage KSQ’s proprietary technology. The company is focusing on launching new products aimed at oncology treatment solutions and expanding into additional markets in Europe and Asia by 2025.
Who invested in KSQ Therapeutics
8 investors across 2 rounds
See all investors in KSQ Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about KSQ Therapeutics
Who invested in KSQ Therapeutics?
KSQ Therapeutics has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has KSQ Therapeutics raised?
KSQ Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did KSQ Therapeutics last raise money?
KSQ Therapeutics's most recent round on record is a Series C, in Sep 2018.
What does KSQ Therapeutics do?
KSQ Therapeutics is a pharmaceuticals company.
Where is KSQ Therapeutics headquartered?
KSQ Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like KSQ Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at KSQ Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like KSQ Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.